Trial Profile
Does a low exhaled Nitric Oxide level exclude a clinical benefit from inhaled corticosteroids in suspected asthma; a double-blind, randomised, placebo controlled trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 03 May 2021 Results assessing efficacy of low exhaled nitric oxide level in patients with suspected asthma, published in the Respirology.
- 10 Feb 2019 Status changed from recruiting to completed.
- 23 Jun 2016 New trial record